Table 4.
Baseline and post-intervention distribution of adherence and depression scores
| Baseline
|
Post-intervention (11 months) |
Follow-up (1 year post-intervention) |
|||||
|---|---|---|---|---|---|---|---|
| Total group (n=38) |
Coaching group (n=18) |
Control group (n=20) |
Coaching group (n=9) |
Control group (n=18) |
Coaching group (n=12) |
Control group (n=12) |
|
| % | % | % | % | % | % | % | |
| Dornase alfa | 76% | 75% | 78% | 67% | 80% | 72% | 90% |
| Low adherencea | |||||||
| Pancreatic enzymes | 50% | 67% | 33% | 67% | 41% | 67% | 55% |
| Low adherencea | |||||||
| Vitamine supplements | 58% | 56% | 60% | 56% | 39% | 67% | 64% |
| Low adherencea | |||||||
| Inhaled antibiotics | 56% | 64% | 50% | 63% | 53% | 64% | 64% |
| Low adherencea | |||||||
| PEP | 74% | 75% | 74% | 78% | 75% | 83% | 100% |
| Low adherencea | |||||||
| MDI | 15.7% | 17% | 15% | 22% | 0 | 8.3% | 8.3% |
| Mild depression | |||||||
| MDI | 2.6% | 0 | 5% | 0 | 5.6% | 0 | 17% |
| Moderate depression | |||||||
| MDI | 7.9% | 5.6% | 10% | 0 | 0 | 8.3% | 0 |
| Severe depression | |||||||
| CES-D depressionb | 26% | 22% | 30% | 22% | 22% | 25% | 25% |
Notes:
a
Low adherence: Morisky Medication Adherence Scale-8 item scores <6.
b
Depression: CES-D scores >16.
Abbreviations: PEP, positive expiratory pressure; MDI, Major Depression Inventory; CES-D, Center for Epidemiologic Studies-Depression Scale.